Repository

Publications

Genomic pathway alterations and their prognostic impact in biliary tract cancer: Insights from a multinational cohort treated with cisplatin, gemcitabine, and durvalumab

Pirrone C, Malapelle U, Pepe F, Lo Prinzi F, Nichetti F, Saborowski A, Antonuzzo L, Camera S, Satake T, Peeters F, Vivaldi C, Pressiani T, Lucchetti J, Kim JW, Abidoye O, Rapposelli IG, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Tamburini E, Yoo C, Parisi A, Diana A, Scartozzi M, Prager GW, Avallone A, Corallo S, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Adeva J, Chan SL, Spinelli GP, Personeni N, Garajova I, Rodriquenz MG, Leo S, Alvim CM, Roque R, Farinea G, Salani F, De Grandis C, Lavacchi D, Persano M, Ikeda M, Dekervel J, Niger M, Balsano R, Tonini G, Kang M, Bekaii-Saab T, Esposito L, Boccaccino A, Himmelsbach V, Landriscina M, De Cobelli F, Ratti F, Daniel F, Tesini G, Masi G, Vogel A, Lonardi S, Rimini M, Fornaro L, Rimassa L, Casadei-Gardini A. Eur J Cancer. 2025 Oct 3;230:116035. doi: 10.1016/j
Eur J Cancer. 2025 Nov 17:230:116035. doi: 10.1016/j.ejca.2025.116035
2025 
Result from  

Epidemiology, Clinical, Molecular Features, and Prognosis of Early-Onset Biliary Tract Cancer: A Systematic Review & Meta-Analysis

Akkus E, Cammarota A, Izquierdo-Sanchez L, Banales JM, Forner A, Lleo A, Macias RIR, Lamarca A, Bouattour M
JHEP Reports. 2025. doi: 10.1016/j.jhepr.2025.101613
2025 
Result from  
OA Funded by  
Results from  

Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer

Castet F, Fabregat-Franco C, Bridgewater J, Kim JW, Rimini M, La Casta A, Lamarca A, Kang M, Salani F, Castillo A, Lopes A, Hyung J, Rimassa L, Adeva J, López-Valbuena D, Basagaña-Farres M, Vaja S, Mak KM, Tian TV, Muñoz A; Spanish Cooperative Group for the Treatment of Digestive Tumors (TTD); Casadei-Gardini A; DURVABTC Group; Yoo C, Valle JW, Macarulla T
J Hepatol. 2025 Nov;83(5):1102-1115. doi: 10.1016/j.jhep.2025.05.020
2025 
Result from  

Evolving Precision: Updates in Targeted Therapy for Cholangiocarcinoma

Tesini G, Ibrahim H, Rimassa L, Braconi C
Hepatology. 2025 Sep 22. doi: 10.1097/HEP.0000000000001541
2025 
Result from  
Funded by  

Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy

Vitiello F, Vivaldi C, Rizzato MD, Saborowski A, Antonuzzo L, Rossari F, Salani F, Kim JW, Rapposelli IG, Tamburini E, Rimini M, Prinzi FL, Satake T, Peeters F, Pressiani T, Lucchetti J, Abidoye O, Gallio C, Tamberi S, Finkelmeier F, Giordano G, Pircher C, Chon HJ, Braconi C, Qaisar A, Pastorino A, Castet F, Yoo C, Scartozzi M, Prager GW, Avallone A, Schirripa M, Kim IH, Perkhofer L, Oneda E, Verrico M, Parisi A, Diana A, Couto N, Chan SL, Garajova I, Roque R, Ikeda M, Niger M, Tonini G, Himmelsbach V, Landriscina M, Masi G, Vogel A, Lonardi S, Fornaro L, Rimassa L, Casadei-Gardini A, Adeva J, Spinelli GP, Personeni N, Rodriguez MG, Leo S, Alvim CM, Farinea G, Genovesi V, De Rosa A, Lavacchi D, Camera S, Dekervel J, Balsano R, Kang M, Tesini G, Esposito L, Boccancino A, Ahcene Djaballah S, Bekaii-Saab T.
Oncology. 2025 Aug 14:1-26. doi: 10.1159/000546856
2025 
Result from  
Join the Action
JOIN